Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Life Sciences
Hardman & Co Healthcare Index
By
Dr Martin Hall
10 Jan 2022
Deepbridge Capital (Funds)
Technology
Deepbridge Technology Growth EIS
By
Dr Brian Moretta
21 Dec 2021
Deepbridge Capital (Funds)
Financials
Deepbridge Life Sciences EIS
By
Dr Brian Moretta
21 Dec 2021
Vala Capital Partners
Financials
Vala Sustainable Growth EIS
By
Dr Brian Moretta
10 Dec 2021
Calculus Capital (Funds)
Financials
Calculus VCT plc
By
Dr Brian Moretta
10 Dec 2021
Calculus Capital (Funds)
Financials
Calculus EIS Fund
By
Dr Brian Moretta
09 Dec 2021
Bank North
Financials
Major steps forward
By
Mark Thomas
08 Dec 2021
Blackfinch Investments (Fund)
Financials
Blackfinch Spring VCT
By
Dr Brian Moretta
07 Dec 2021
Cizzle Biotechnology
Life Sciences
News flow driven by deals
By
Dr Martin Hall
07 Dec 2021
Pantheon International Plc
Investment Companies
Primary platform + active management = value add
By
Mark Thomas
07 Dec 2021
Palace Capital
Property
Interim results: ammunition for major dividend rises
By
Mike Foster
03 Dec 2021
Prev
1
...
22
23
24
25
26
...
81
Next